Dr. Simon P. Horslen

Simon Horslen, MBChB, FRCPCH, is a pediatric hepatologist and transplant physician and is certified in General Pediatrics and Gastroenterology by the Medical Royal Colleges in the United Kingdom. He is director of Pediatric Hepatology at UPMC Children’s Hospital of Pittsburgh and is a professor at the University of Pittsburgh School of Medicine. Dr. Horslen earned his medical degree at the University of Bristol Medical School in England and is a fellow and founding member of the Royal College of Pediatrics and Child Health (UK). He is a fellow of the American Society of Transplantation and of the American Association for the Study of Liver Disease. Dr. Horslen has worked in the United States for the last 23 years, initially at the University of Nebraska Medical Center in Omaha, NE, and subsequently at Seattle Children’s in Seattle, WA as director of Hepatology and medical director of Solid Organ Transplantation. His clinical and research interests include pediatric liver disease, acute liver failure, and liver and intestine transplantation. He has over 150 publications in the areas of pediatric liver disease, intestinal failure, and transplantation and participates in several multicenter studies. Dr. Horslen lives in Edgeworth with his wife, Sarah. He has two adult children who continue to live in the Pacific Northwest. He is an avid soccer fan, likes to play golf when his busy schedule allows, and is a woodturner and particularly enjoys making bowls on his lathe. View the full list of Dr. Horslen’s publications on PubMed. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling.

Dr. Horslen is rated as a Distinguished provider by MediFind in the treatment of Progressive Familial Intrahepatic Cholestasis Type 1. His top areas of expertise are Short Bowel Syndrome, Cholestasis, Progressive Familial Intrahepatic Cholestasis Type 1, Alagille Syndrome, and Liver Transplant.

His clinical research consists of co-authoring 136 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 2 clinical trials in the study of Progressive Familial Intrahepatic Cholestasis Type 1.